Medindia

X

Foamix Extends Collaboration with Galderma

Wednesday, November 4, 2009 General News J E 4
Advertisement
REHOVOT, Israel, November 3 Foamix Ltd, a global leaderin the development of dermatological foam medications today announced thatthe company has extended its agreement with Galderma to develop an innovativemedicated foam for an additional dermatological indication. This newtreatment contains a novel drug for the therapy of certain skin diseases.

Under this agreement, Foamix will develop the foam formulation of theproduct and Galderma will subsequently conduct all other activities(clinical, non-clinical, etc). Foamix will receive staged payments onsuccessful completion of the technical milestones of the project.

About Foamix:

Headquartered in Rehovot, Israel, Foamix Ltd. is a leading developer oftopical and mucosal foams for dermatological and gynecological applications.Foamix's state-of-the-art foams provide controlled delivery of a variety ofactive ingredients. Foamix is currently collaborating with major, medium andsmall pharmaceutical and cosmetic companies on a plurality of projects in thedevelopment of proprietary dermatological and gynecologic foam drugs.Additionally, the Company has an in-house pipeline of dermatological andgynecological drugs in foam presentation.

To date, Foamix has seventeen issued patents worldwide covering its foamand OilGel technology platforms and in excess of 150 pending applications ofwhich more than a third are filed in the United States. The Company employs aleading U.S. patent counsel (WilmerHale LLC).

For additional information, please visit http://www.foamix.co.il.

Press inquiries: Sigal Maymon, Foamix Ltd, +972-8-9316233 orinfo@foamix.co.il

SOURCE Foamix Ltd
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds Wheelchair Market Shares, Strate...
S
AACE Issues New Medical Guidelines for Proper and ...